Skip to main content

Volume 12 - Issue 2 - February 2012

Column

Letter from the Editor
01/27/2012
On December 14, 2011, the Food and Drug Administration classified St. Jude Medical’s Riata defibrillator lead as a Class I recall, because of the “potential risk of serious injury or patient death if affected devices malfunction.”
On December 14, 2011, the Food and Drug Administration classified St. Jude Medical’s Riata defibrillator lead as a Class I recall, because of the “potential risk of serious injury or patient death if affected devices malfunction.”
On December 14, 2011, the Food...
01/27/2012
EP Lab Digest
Spotlight Interview
01/26/2012
Merkezi Klinika Hospital is located in the center of Baku, the capital of the Azerbaijan Republic. It is equipped with the latest technology and offers a full range of state-of-the-art diagnostic and therapeutic cardiovascular services.
Merkezi Klinika Hospital is located in the center of Baku, the capital of the Azerbaijan Republic. It is equipped with the latest technology and offers a full range of state-of-the-art diagnostic and therapeutic cardiovascular services.
Merkezi Klinika Hospital is...
01/26/2012
EP Lab Digest

Feature

Review
01/27/2012
We are at the cusp of a new era of ablation for arrhythmias similar to the transition 25 years ago when RF supplanted direct current energy.
We are at the cusp of a new era of ablation for arrhythmias similar to the transition 25 years ago when RF supplanted direct current energy.
We are at the cusp of a new era...
01/27/2012
EP Lab Digest
Case Study
01/27/2012
Shawn Balaschak, RN, BSN, MS, presents a brief case study on a patient with Twiddler’s syndrome. Find out more about this unusual phenomenon here.
Shawn Balaschak, RN, BSN, MS, presents a brief case study on a patient with Twiddler’s syndrome. Find out more about this unusual phenomenon here.
Shawn Balaschak, RN, BSN, MS,...
01/27/2012
EP Lab Digest
Case Study
01/26/2012
This case illustrates a realistic dilemma when medical therapy has no additional benefit. Both VAD and transplant therapy have been shown to be helpful in certain patient populations, but it may not be applicable in all heart failure...
This case illustrates a realistic dilemma when medical therapy has no additional benefit. Both VAD and transplant therapy have been shown to be helpful in certain patient populations, but it may not be applicable in all heart failure...
This case illustrates a...
01/26/2012
EP Lab Digest
Feature Story
01/26/2012
The ability to use MR scans is important and will become even more important in the future. Until recently, patients with an ICD had been excluded from undergoing MR scans despite that these scans are critical for the diagnosis and therapy of...
The ability to use MR scans is important and will become even more important in the future. Until recently, patients with an ICD had been excluded from undergoing MR scans despite that these scans are critical for the diagnosis and therapy of...
The ability to use MR scans is...
01/26/2012
EP Lab Digest
Review
01/26/2012
Recently, dabigatran was approved for stroke prevention in the AF population, followed closely by rivaroxaban. Apixaban is also currently undergoing FDA review. The following is a summary of these new warfarin rivals.
Recently, dabigatran was approved for stroke prevention in the AF population, followed closely by rivaroxaban. Apixaban is also currently undergoing FDA review. The following is a summary of these new warfarin rivals.
Recently, dabigatran was...
01/26/2012
EP Lab Digest
Feature Story
01/25/2012
The Society of Chest Pain Centers recently selected Genesis HealthCare System as one of 5 hospitals in the nation to participate in beta site testing for the forthcoming Atrial Fibrillation Certification. 
The Society of Chest Pain Centers recently selected Genesis HealthCare System as one of 5 hospitals in the nation to participate in beta site testing for the forthcoming Atrial Fibrillation Certification. 
The Society of Chest Pain...
01/25/2012
EP Lab Digest

Insights

10-Minute Interview
01/27/2012
EPLD speaks with Jagmeet P. Singh, MD, DPhil, Associate Professor of Medicine, Harvard Medical School, Cardiac Arrhythmia Service, Massachusetts General Hospital Heart Center.
EPLD speaks with Jagmeet P. Singh, MD, DPhil, Associate Professor of Medicine, Harvard Medical School, Cardiac Arrhythmia Service, Massachusetts General Hospital Heart Center.
EPLD speaks with Jagmeet P....
01/27/2012
EP Lab Digest